Congressional Testimony

An Active Presence on Capitol Hill

Recognizing the need for more research into causes and treatments of functional gastrointestinal and motility disorders,IFFGD has provided oral and/or written testimony to Congressional subcommittees many times over the years.

Each fiscal year (FY), Congress decides how much funding to provide federally supported medical research initiatives, what areas of research should be prioritized, and how much funding should be committed towards new drug approval and the monitoring of current treatment options.Whenever appropriate, IFFGD offers testimony which expresses the needs of functional GI and motility disorder patients and urges additional resources for the National Institutes of Health (NIH) and Food & Drug Administration (FDA).

IFFGD has presented the needs of the digestive health community to both the Senate and the House Appropriations Subcommittees on Labor, Health & Human Services, Education and Related Agencies, as well as the Senate Appropriations Subcommittee on Defense.

June 6, 2012

IFFGD provided oral testimony regarding Fiscal Year 2013 appropriations for the Department of Defense (DOD) Gulf War Illness Research Program to the U.S Senate Appropriations Committee, Subcommittee On Defense. Read the full testimony here.

June 22, 2011

IFFGD presented oral testimony regarding Fiscal Year 2012 appropriations for the Department of Defense (DOD) Peer Reviewed Medical Research Program to the U.S. Senate Appropriations Committee, Subcommittee On Defense. View video or read the full testimony here.

May 1, 2009

IFFGD submitted written testimony to the House Committee on Appropriations; Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding Fiscal Year 2010 appropriations for the National Institutes of Health. Read the full testimony here.

April 28, 2008

IFFGD provided written testimony regarding Fiscal Year 2009 appropriations for the National Institutes of Health to the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies. Read the full testimony here.

March 27, 2007

IFFGD provided oral testimony regarding Fiscal Year 2008 Funding for Functional Gastrointestinal and Motility Disorders Research before the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies. Read the full testimony here.

May 19, 2006

IFFGD presented oral testimony to both the U.S. Senate and U.S. House Appropriations Subcommittees on Labor, Health & Human Services, Education and Related Agencies regarding Fiscal Year 2007 Funding for Functional Gastrointestinal and Motility Disorders Research. Read the full testimony here.

2005

IFFGD provided oral testimony before the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies regarding Fiscal Year 2006 Funding for Functional Gastrointestinal and Motility Disorders Research. Read the full testimony here.

2004

IFFGD presented oral testimony regarding Fiscal Year 2005 Funding for Functional Gastrointestinal and Motility Disorders Research before the House Appropriations subcommittee on Labor, Health & Human Services, Education and Related Agencies. Read the full testimony here.

May 7, 2003

IFFGD provided oral testimony before the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies regarding Fiscal Year 2004 Funding for Functional Gastrointestinal and Motility Disorders Research. Read the full testimony here.

May 2, 2002

IFFGD presented oral testimony regarding Fiscal Year 2003 Irritable Bowel Syndrome Research to the House Appropriations Subcommittee on Labor, Health & Human Services, Education and Related Agencies. Read the full testimony here.